Financials

News Ideas Minds Technicals

XIN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Shandong Xinhua Pharmaceutical Co. Ltd. operating, investing, and financing activities

XIN free cash flow for Q1 24 is -1.86 M EUR. For 2023, XIN free cash flow was -6.63 M EUR and operating cash flow was 35.05 M EUR.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—